The Food and Drug Administration on Friday gave final approval to a proposal to release genetically modified mosquitoes just outside Key West, Fla., in an effort to reduce outbreaks of transmittable viruses, including Zika, according to M&C's sister publication, Travel Weekly. The proposed trial would not have significant impact on the environment, the agency said.
The FDA's final decision came nearly five months after it had given preliminary approval to the plan and during the same week that the first nontravel-related Zika outbreak in the U.S. was confirmed in the Miami area. Nevertheless, it will likely be at least December before the genetically modified mosquitoes are deployed, said Beth Ranson, spokesperson for the Florida Keys Mosquito Control District, which would run the trial program.
For the full article, click here.